单位(元)天弘国证生物医药ETF发起式联接C(011041)资产负债表 |
| 报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
| 资产 |
| 银行存款 |
61,925,485 |
63,534,487 |
56,661,054 |
55,685,341 |
| 结算备付金 |
267,784 |
1,516,100 |
398,227 |
892,130 |
| 存出保证金 |
382,713 |
542,653 |
676,425 |
701,961 |
| 交易性金融资产 |
1,147,751,854 |
1,163,410,123 |
988,689,141 |
967,215,058 |
| 其中：股票投资 |
54,330,973 |
44,916,772 |
14,591,641 |
28,875,368 |
| 基金投资 |
1,091,904,361 |
1,117,280,035 |
973,894,931 |
938,339,690 |
| 债券投资 |
1,516,520 |
1,213,316 |
202,568 |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
2,788,625 |
25,820,614 |
13,096,282 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
9,885,889 |
9,191,985 |
2,881,745 |
11,193,033 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
1,220,213,726 |
1,240,983,973 |
1,075,127,205 |
1,048,783,806 |
| 负债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
1,919,271 |
2,602,081 |
- |
- |
| 应付赎回款 |
9,422,428 |
11,796,331 |
33,005,854 |
28,314,874 |
| 应付管理人报酬 |
48,038 |
41,884 |
38,878 |
31,471 |
| 应付托管费 |
9,608 |
8,377 |
7,776 |
6,294 |
| 应付销售服务费 |
176,632 |
181,591 |
159,174 |
129,887 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
271,157 |
184,885 |
334,410 |
251,658 |
| 负债合计 |
11,847,134 |
14,815,148 |
33,546,092 |
28,734,184 |
| 所有者权益 |
| 实收基金 |
2,392,914,307 |
2,462,765,506 |
1,671,293,409 |
1,377,489,306 |
| 未分配利润 |
-1,184,547,715 |
-1,236,596,681 |
-629,712,296 |
-357,439,684 |
| 所有者权益合计 |
1,208,366,592 |
1,226,168,825 |
1,041,581,113 |
1,020,049,622 |
| 负债和所有者权益总计 |
1,220,213,726 |
1,240,983,973 |
1,075,127,205 |
1,048,783,806 |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
